1. "Neuronal Adaptations and Counter-Adaptations" -which addresses the fact that the abused substances produce long-lasting changes in neuronal morphology and function. These changes are due to the pharmacological effects of drugs on the nervous system, which invoke brain systems involved in reward processing and learning, among other processes. These changes may be considered neuroadaptive or neuropathological. The cellular mechanisms that regulate neural circuitry function are being uncovered and their relevance to addiction explored. 2. "Heteromerization of G-Protein-Coupled Receptors: Implications for CNS Function and Dysfunction" -focuses on the emerging area of heteromerization of neurotransmitter receptors. Several receptor classes in the CNS confer functional entities that possess different biochemical characteristics with respect to the individual components of the heteromer. Discovery of this phenomenon is changing traditional notions about neurotransmission. Receptors are now recognized to form multimolecular aggregates localized in the plasma membrane, which when stimulated, lead to functional changes in cell signaling. In this special issue, the symposium contributors review the roles of dopamine, opioid, and adenosine receptor heteromers in the CNS. Their implications for neuropsychiatric disorders, including drug addiction and agonist-and antagonist-heteromeric interactions, are discussed. 3. "Glial Cells and Addiction" -highlights recent discoveries that have led to a new appreciation of glial function. It was known previously that glia performed metabolic functions in the CNS, but recent research has shown that glia can release chemical transmitters, and play a role in synaptic formation, neural development, neuroplasticity, pain modulation, and substance abuse. 4. "Impulsivity and Addiction: A Tribute to Henri Begleiter" -co-sponsored with National
Institute on Alcohol Abuse and Alcoholism (NIAAA) commemorates and complements the work of the late Dr. Henri Begleiter, who made the landmark discovery that P 300 amplitude could be used to differentiate between children of alcoholics and non-alcoholics. This result, among others, led to the exploration of alternative diagnostic phenotypes that could be linked to alcoholism susceptibility genes and their neurobiological correlates, in order to identify "endophenotypes" of the disease itself. Since endophenotypes are proximal to gene function, they provide a unique approach to the discovery of genes and genetic risk factors contributing to complex behavioral phenotypes, such as substance use disorder.
Contributions to this issue from the three NIDA-supported SfN symposia include:
1. "Understanding the Neurobiology of Drug Addiction by Studying Sleep Disturbances and Circadian Rhythms" -capitalizes on the observation that a hallmark of drug dependence, as well as other psychiatric disorders, is sleep disturbance. Drugs of abuse may alter or disrupt brain circuitry involved in regulating circadian systems, leading not only to changes in sleep, but to sleep-related cognitive function. Further, drugs of abuse can entrain circadian patterns of behavior. Thus, genes that influence circadian rhythms are implicated in the regulation of drug sensitization and reward, which may be mediated through the mesolimbic dopaminergic system. 2. "Noncoding RNAs in the Brain" -highlights the intense research efforts to identify neuronal specific RNAs and their role in post-transcriptional gene regulation during neural development and disease. 3. "Reconciling Molecular and Electrophysiological Effects of Cocaine on Neural Plasticity" -examines the physiological and molecular changes in the nucleus accumbens that show evidence of hypoactivity following cocaine exposure and other changes indicative of enhanced responsiveness, such as changes in glutamate receptor distribution, signaling, and gene expression. This paradox is discussed in this issue.
In summary, while not exhaustive of the neuroscience research that NIDA supports, this special issue highlights the innovation, breadth, and diversity of the NIDA neuroscience research portfolio. It also exemplifies the need for NIDA to continue to support a variety of basic and clinical neurobiological investigations in order to uncover the ever-elusive mechanisms that contribute to drug addiction. At the same time, the research that NIDA supports must be applied to and translated into advances in and the development of new medications and therapies that will have a direct impact on this serious public health problem. Investment in basic and clinical research such as that highlighted in this special issue will contribute to this effort.
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